November 1, 2011
Masayo Tada, President and CEO, Dainippon Sumitomo Pharma Masayo Tada, president and CEO of Dainippon Sumitomo Pharma (DSP), told reporters at a company earnings announcement on October 31 that DSP is targeting early maximization of atypical antipsychotic Lonasen (blonanserin), one...read more